The year in gout brings a controversial new drug

MAUI, HAWAII – The recently approved uric acid–lowering drug lesinurad received a lukewarm reception at best when introduced during a ‘highlights of the year in gout’ session presented at the 2016...

Source: Rheumatology News - April 20, 2016 Category: Rheumatology Source Type: research